Understanding the lives and needs of Hemophilia patients

 Understanding the lives and needs of Hemophilia patients

The Challenge

Our client needed to understand the challenges and unmet needs in Hemophilia A & B in preparation for the launch of two new products. Research was required to deliver practical and actionable recommendations to maximize the opportunity in a crowded landscape. Our client wanted to look at the options for doing so through the development of digital ‘value-added’ tools and service wraps.

Our Approach

On our recommendation, our client commissioned us to conduct qualitative research with hematologists. In the research we used a range of in-depth research techniques, including creative ideation approaches. These included pictorial metaphor elicitation, 100-point distribution exercises and patient record form tasks. Using these methods we were able to landscape the disease area and develop a deep understanding of customer needs. Through this approach were able to pinpoint key areas of opportunity.

The Outcome

We used the research to create a map of the treatment journey, highlighting key touchpoints and challenges for specific patient populations. In particular the need for targeted educational materials was identified. The insights were used to aid in the creation and delivery of these materials. The practical roadmap and toolbox that Bryter delivered allowed our client to focus their efforts on the unmet needs of their customers, using both traditional solutions and novel digital tools.

Related case studies

Supporting rare disease market entry: Building a European market access strategy
Supporting rare disease market entry: Building a European market access strategy

View case study

Optimising patient communications: Adcept and message testing for a Multiple Myeloma campaign
Optimising patient communications: Adcept and message testing for a Multiple Myeloma campaign

View case study

Informing launch strategy: Supporting successful market entry and growth in rare disease
Informing launch strategy: Supporting successful market entry and growth in rare disease

View case study